Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: GlobalData
$250.00
Provider: GlobalData
$125.00
Provider: Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Osprey Medical Inc announces publication of the AVERT System pilot clinical trial in Journal


Wednesday, 1 Jan 2014 04:41pm EST 

Osprey Medical Inc:Says publication of results from the pilot clinical trial of the AVERT system (Contrast Conservation System/CCS).Says the study which was conducted in late 2012 at the Alfred Hospital in Melbourne Australia by Dr David Kaye and Dr Stephen Duffy, was titled Reducing iodinated contrast volume by manipulating injection pressure during coronary angiography.Says it was published ahead of press on-line in the Dec. 2013 edition of Catheterization and Cardiovascular Interventions.Says the 21-patient pilot clinical trial, demonstrated that the use of the AVERT System was associated with a highly significant 40 pct reduction in dye injection compared with standard imaging techniques, whilst maintaining image quality. 

Company Quote

0.555
-0.015 -2.63%
12:03am EDT